Trial Profile
Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2023
Price :
$35
*
At a glance
- Drugs Auranofin (Primary) ; Dendritic cell vaccines (Primary) ; Dolutegravir (Primary) ; Maraviroc (Primary) ; Nicotinamide (Primary)
- Indications HIV-1 infections
- Focus Proof of concept; Therapeutic Use
- 22 Feb 2023 Results presented at the 30th Conference on Retroviruses and Opportunistic Infections 2023
- 10 Mar 2021 Results of a single patients the long-term stability of post-ATI control presented at the 28th Conference on Retroviruses and Opportunistic Infections
- 25 Jul 2020 Status changed from active, no longer recruiting to completed.